Joseph Marks - Jun 16, 2023 Form 4 Insider Report for Augmedix, Inc. (AUGX)

Role
Director
Signature
/s/ Paul Ginocchio, Attorney-in-Fact
Stock symbol
AUGX
Transactions as of
Jun 16, 2023
Transactions value $
$0
Form type
4
Date filed
6/16/2023, 05:48 PM
Previous filing
Jun 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Options Exercise +52.6K 52.6K Jun 16, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUGX Restricted Stock Units Options Exercise $0 -52.6K -100% $0.00* 0 Jun 16, 2023 Common Stock 52.6K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.
F2 On June 16, 2022 (the "Grant Date"), the reporting person was granted 52,632 RSUs which vested in full on the one-year anniversary of the Grant Date.